SiaA: A Heme Protein by Libkind, Marianna
Georgia State University
ScholarWorks @ Georgia State University
Chemistry Honors Theses Department of Chemistry
2-19-2007
SiaA: A Heme Protein
Marianna Libkind
Follow this and additional works at: https://scholarworks.gsu.edu/chemistry_hontheses
This Thesis is brought to you for free and open access by the Department of Chemistry at ScholarWorks @ Georgia State University. It has been
accepted for inclusion in Chemistry Honors Theses by an authorized administrator of ScholarWorks @ Georgia State University. For more information,
please contact scholarworks@gsu.edu.
Recommended Citation
Libkind, Marianna, "SiaA: A Heme Protein." Thesis, Georgia State University, 2007.
https://scholarworks.gsu.edu/chemistry_hontheses/2
         SiaA: A HEME PROTEIN 
 
by 
 
MARIANNA LIBKIND 
 
Under the Direction of Dabney White Dixon 
 
 
 
 
 
ABSTRACT 
 
 The protein SiaA (Streptococcal iron acquisition) is involved in heme uptake in the 
bacterium Streptococcus pyogenes.  It is difficult to obtain this protein in its fully holo form 
(completely loaded with heme).  To increase the concentration of heme in the growing cell, we 
added δ-aminolevulinic acid (ALA) and ferrous sulfate (FeSO4), precursors of heme, to the 
growth media.  Neither increasing the concentration of heme in vivo, nor growth at lower 
temperature for longer times, increased the production of holoprotein.  The classical method of 
measuring the concentration of heme in a newly discovered heme protein is cumbersome.  We 
have developed an improved method, which gives a solution that is more stable and has a cleaner 
spectrum.  With further development, this new technique may replace the classical assay.  
Background information on S. pyogenes, SiaA, ABC transporters, heme biosynthesis, and the 
pyridine hemochrome assay are described.   
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Introduction 
 Some bacteria need heme for survival (Figure 1) (Perkins-Balding et al., 2004).  Heme 
may serve as the major sole source of iron, which is key for a variety of cellular processes.  
Some bacteria take up iron using an ATP-binding cassette (ABC) transporter system, in which a 
protein on the exterior of the cell picks up heme, and transfers it to a membrane protein, which 
transports it into the cell.    
 In the bacterium Streptococcus pyogenes, the protein SiaA (Streptococcal iron 
acquisition) is involved in heme uptake.  Work in other laboratories, as well as in our own, has 
shown that it is difficult to obtain this protein in its fully holo form (completely loaded with 
heme).  One strategy to increase the amount of heme in solution is to add heme precursors to the 
growth media.  A second technique is to grow the protein at a lower temperature, for longer 
duration, with shaking at a lower speed.  Herein, we report attempts to increase the amount of 
holoprotein using both of these techniques. 
 It is difficult to measure the concentration of heme in a novel heme protein.  We report 
the development of an improved method, which is both easier to implement and gives a more 
stable solution.     
 
Streptococcus pyogenes 
 S. pyogenes is a Gram-positive bacterium and is nonmotile (Bates et al., 2003). The 
metabolism of S. pyogenes is fermentative; therefore, it does not require oxygen to survive. S. 
pyogenes is also a common human pathogen. S. pyogenes can produce infections such as scarlet 
fever, pharyngitis (strep throat), impetigo (infections of the superficial layers of the skin), and 
cellulitis (infection of the deep layers of the skin). It can also produce streptococcal toxic shock 
syndrome (Bates et al., 2003; Lei et al., 2003). 
 S. pyogenes uses iron for growth, and heme compounds are necessary sources of iron for 
infection. Bates et al. have shown that whole blood can support S. pyogenes growth in iron-
depleted medium (Bates et al., 2003). Hemolysis is used by this pathogen to obtain iron and this 
idea is consistent with the hemolytic nature of S. pyogenes. Hemolytic S. pyogenes can use heme 
from various sources and can make use of hemoglobin, myoglobin, heme-albumin, and the 
hemoglobin-haptoglobin complex. S. pyogenes is not able to use ferric carriers in the serum and 
secretions such as transferrin and lactoferrin. Surface proteins help streptococcal binding of 
hemoproteins, which is most likely seen as the first step in the process of bacteria capturing iron.  
Hyalauronic acid is capable of assisting S. pyogenes’ surface to bind free heme because of the 
interactions between polysaccharides and heme. Bates et al. have shown that in S. pyogenes cells 
grown at 40 °C, gene expression was affected by the restriction of iron in ways including the 
induction of genes encoding a putative iron transporter, hemolysins, and iron-dependent 
repressors (Bates et al., 2003).  
 
SiaA 
 A highly preserved, iron-regulated, ten gene operon is expressed by S. pyogenes to bring 
in iron ions into the cytoplasm (Figure 2). This has been termed the Sia (Streptococcal Iron 
Acquisition) transporter by Eichenbaum and co-workers (Bates et al., 2003), and HtsA by Lui, 
Lei and co-workers (Lei et al., 2002; Lei et al., 2003; Liu & Lei, 2005a; Liu & Lei, 2005b; 
Nygaard et al., 2006).  SiaA is of the ABC (ATP-Binding Cassette) transporter family. ABC 
transporters assist the translocation of substrates, in one direction, across membranes with the 
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use of ATP (Locher, 2004). The Sia transporter consists of a lipoprotein, SiaA, membrane 
permease, SiaB, and ATPase, SiaC (Figure 3).  The production of SiaA is induced by iron 
restriction (Bates et al., 2003).   
 SiaA is located in a ten gene operon that is iron regulated (Bates et al., 2003). Sequence 
analysis shows that siaABC appear as genes three through five in the operon (Bates et al., 2003). 
The genes encoded by the Sia operon are transcriptionally linked. Under the conditions of metal 
cations (e.g. Ca2+, Zn2+, Mn2+, and Mg2+) depletion, the transcription of SiaA is up-regulated (Lei 
et al., 2003). The operon is also able to code for Shr, which is a protein that is associated with the 
surface and binds in vitro to various heme compounds. It is also the closest up stream gene 
cluster within the operon. Heme in the host proteins can be extracted by Shp and Shr and then 
passed on to SiaA. 
  Wild type SiaA has a mass of 33 kDa and a pI of 5.8.  It is anchored by a membrane-
bound tail (Lei et al., 2003; Bates et al., 2003).  SiaA is a cell surface exposed protein; the 
exposure is necessary to obtain heme from the host or from hemoproteins (Lei et al., 2003).  
SiaA binds heme during the transfer from a heme protein or from a solution. Once it binds, SiaA 
transfers the heme to permease SiaB.  
 SiaA is mostly α-helical as shown by circular dichroism (B. Sook, unpublished).  It is 
homologous to BtuF, which is a cobalamin-binding protein (Karpowich et al., 2003).  The 
homology program 3D Jigsaw has been used to identify possible axial ligands of SiaA, which 
include Tyr179, Met66, and His216.  All of these are located next to the probable binding pocket 
(B. Sook, unpublished).   
 WT SiaA is capable of binding various heme proteins as well as heme itself. SiaA can 
form a stable compound with hemoglobin, but is not able to bind myoglobin or the hemoglobin-
haptoglobin complex (Bates et al., 2003).  Bates et al. found that recombinant SiaA binds 
hemoglobin specifically via Western blot and SDS-PAGE analysis (Bates et al., 2003). Via 
enterokinase digest and hemoglobin-binding assays, Bates et al. showed that both rSiaA with a 
His-Xpress epitope and rSiaA without an epitope were able to bind hemoglobin.  
 Eichenbaum and co-workers cloned recombinant SiaA (rSiaA) without a lipoprotein tail; 
a His tag and express epitope were added at the N-terminal end of the construct (Bates et al., 
2003).  Liu and Lei showed that when SiaA is expressed and purified in Escherichia coli, it has 
an intense red color, which signifies the presence of heme (Lei et al., 2003). A typical UV-visible 
absorption spectrum displayed heme peaks at approximately wavelengths 275, 370, 417, 530, 
and 560 nm (Lei et al., 2003). Via ICP-MS, Lui and Lei showed that SiaA as isolated contained 
about 0.25 bound heme molecules, whereas reconstituted SiaA contained about 1.0 bound heme 
molecules (Lei et al., 2003). 
 
ABC transporters 
 ATP-binding cassette (ABC) transporters are integral membrane proteins that consist of a 
solute-binding lipoprotein, one or two membrane spanning permeases, and an ATPase. The 
proteins are usually organized into an operon (Locher, 2004; Jones & George, 2004)}.  
 ABC transporters promote the movement of substrates across membranes in a single 
direction with the use of ATP (Locher, 2004). ABC transporters are engaged in cellular 
processes such as nutrient uptake, bacterial immunity, and cell division, through the transport of 
ions, amino acids, and lipids(Jones & George, 2004). In order to establish homeostasis, ABC 
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transporters import basic and necessary nutrients, concentrate them and expel toxins that have 
accumulated from the environment or may have acquired from metabolic by-products.  
 ABC transporters are characterized by their conserved core structure of four domains, 
which include two alpha-helical transmembrane domains (TMD) and two cytosolic nucleotide-
binding domains (NBD) (Jones & George, 2004). TMDs consist of a number of hydrophobic 
segments, which extend through the membrane and form the transmembrane channel (TM). They 
also contain the substrate binding site. The nucleotide-binding domains contain the highly 
conserved Walker A and B consensus motifs for nucleotide binding. The Walker A motif (G-X-
X-G-X-G-K-S/T) forms a P-loop (phosphate binding loop), a loop full of glycine trailed by an 
uncapped α helix. The P-loop functions to bind the nucleotide by electrostatic interactions with 
the triphosphate region. The Walker B motif is Θ-Θ-Θ-Θ-D, where Θ represents a hydrophobic 
residue. This motif forms a buried ß strand where hydrogen bonding allows the aspartate to 
orient the active site. NMDs are molecular motors that convert the chemical potential energy of 
ATP into protein conformational changes.  
 ABC proteins are found in both prokaryotes and eukaryotes. Prokaryotes have mostly 
importers, although they may have export ABC transporters. Prokaryotic proteins such as 
accessory periplasmic-binding proteins function to gather and give the solute to the membrane-
bound transporters. Eukaryotes, unlike prokaryotes, only have export ABC transporters. The core 
structure of eukaryotic proteins has a single polypeptide, and each transmembrane domain is 
found C-terminal to each nucleotide-binding domain. ABC importers have TMDs that range 
from 8 to 20 transmembrane helices, while ABC exporters have TMDs with 12 transmembrane 
helices. The transmembrane helices of both the exporters and the importers are connected by an 
intracellular domain (Locher, 2004). Half-transporters also exist in both eukaryotes and 
prokaryotes. In these each transmembrane domain may be covalently fused directly to a C-
terminal nucleotide-binding domain or may initially be fused to the N-terminal of a nucleotide 
binding domain and then followed by a transmembrane domain. The entire core structure of half-
transporters can be homo- or heterodimers. 
 The E. coli vitamin B12 importer, BtuCD, is similar overall to SiaA (Locher, 2004). The 
X-ray structure shows that the BtuC dimer forms ten helices from two transmembrane domains. 
The BtuD dimer forms the nucleotide-binding domains. At the interface of the two BtuC 
subunits, a single translocation pathway is present. Since the residues close the cavity, there is no 
continuous pathway across the membrane. The BtuD subunits have a head-to-tail arrangement; 
so that two ATP hydrolysis sites are formed at the dimer interface between the P-loop of one 
subunit and the ABC signature motif of another subunit. 
Heme biosynthesis 
 Heme synthesis occurs in eight enzyme-catalyzed steps. These steps all occur either in 
the mitochondrion, where the major metabolic reactions take place, or in the cytosol. All of the 
atoms in the heme molecule are derived from ALA or from an ALA precursor such as glutamic 
acid or succinic acid (Milgrom, 1997). An abbreviated diagram of the heme biosynthetic 
pathway can be seen in Figure 4. 
 The first step begins in the mitochondrion with the condensation of glycine and succinyl-
CoA, an intermediate form the citric acid cycle, by the pyridoxal phosphate containing enzyme 
δ-aminolevulinic acid (ALA) synthase. ALA synthase, a PLP enzyme in mitochondria, catalyzes 
the committed step of the heme synthesis pathway (Berg et al., 2006). After decarboxylation of 
succinyl-CoA and glycine with ALA synthase, ALA is formed within the matrix of the 
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mitochondrion and transported to the cytosol. This route to the formation of ALA is known as 
the Shemin pathway (Milgrom, 1997). ALA is a precursor to heme; if ALA is abundant it may 
increase heme production which in turn may lead to higher concentration of heme in vivo 
(Rivera & Walker, 1995). Heme acts as a feedback inhibitor, repressing transcription of the gene 
for ΑLA synthase in most cells (Berg et al., 2006). 
 In the cytosol, ALA dehydratase condenses two molecules of ALA to produce the pyrrole 
ring compound porphobilinogen (PBG) (Berg et al., 2006). Labeled PBG has been inserted into 
heme by the use of chicken blood as the biosynthetic system (Milgrom, 1997). This biosynthetic 
system is also very similar to Knorr pyrrole synthesis, a common method of making pyrroles in a 
laboratory. The third step includes the head-to-tail condensation of four molecules of PBG to 
produce a linear tetrapyrrole intermediate, hydroxymethylbilane, a reaction catalyzed by PBG 
deaminase (Rivera & Walker, 1995). An ammonium ion is released from each methylene bridge 
and the linear tetrapyrrole cyclizes to form uroporphyrinogen III, which has an asymmetric 
arrangement of side chains (Berg et al., 2006). This reaction is catalyzed by uroporphyrinogen III 
cosynthase. In the linear tetrapyrrole formed by the four PBG molecules, one of the PBG units is 
reversed giving the type III isomer. This reaction requires both of the enzymes; if 
uroporphyrinogen III cosynthase is not present then only uroporphyrinogen I is produced 
(Milgrom, 1997).  
 The acetate substituents of uroporphyrinogen III are decarboxylated by the enzyme 
uroporphyrinogen decarboxylase to methyl groups forming coproporphyrinogen III(Rivera & 
Walker, 1995). Coproporphyrinogen III is then transported to the interior of the mitochondrion, 
where desaturation of the porphyrin ring and the conversion of two of the propionate side chains 
into vinyl groups leads to protoporphyrinogen IX, catalyzed by the enzyme coproporphyrinogen 
III oxidase (Milgrom). In the mitochondrion, protoporphyrinogen IX is converted to 
protoporphyrin IX by protoporphyrinogen IX oxidase (Berg et al., 2006), found in the inner 
mitochondrial membrane (Milgrom, 1997). This oxidase reaction requires molecular oxygen 
(Milgrom, 1997). The loss of six electrons and six protons yields a completely conjugated ring 
system (Rivera & Walker, 1995). This conjugated ring system is responsible for the 
characteristic red color of heme (Berg et al., 2006).  
 The final reaction in heme synthesis, which also takes place in the mitochondrion, 
involves the insertion of the ferrous form of iron into the ring system (Rivera & Walker, 1995).  
Iron is transported in the plasma by transferrin, a protein that binds ferric ions. The enzyme 
catalyzing this reaction is known as ferrochelatase and is bound to the inner mitochondrial 
membrane (Berg et al., 2006). In proteins with a non-covalently bound heme such as 
hemoglobin, myoglobin, catalase, peroxidases and cytochrome b, the reaction between heme and 
the apoprotein occurs spontaneously; therefore, it does not require a catalyst. For a protein with a 
covalently bound heme such as cytochrome c, the reaction does not occur spontaneously; 
therefore, it requires a catalyst (Milgrom, 1997).  
Enhancing heme production with ALA and Fe(II)SO4 
 All of the atoms in the heme molecule are derived from ALA or from an ALA precursor 
such as glutamic acid or succinic acid (Rivera & Walker, 1995).  The first committed precursor 
in the biosynthetic pathway of heme is δ-aminolevulinic acid (ALA) (Figure 4).    
 When iron(II) is present in conjunction with ALA in a culture medium, the biosynthesis 
of heme proceeds to a greater extent than without ALA, resulting in a higher concentration of 
free heme.  For example, Rivera has shown that the addition of ALA in combination with iron(II) 
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increased the yield of holocytochrome b5, and an increase in the concentration of ALA produced 
an increase the concentration of holocytochrome b5 (Rivera & Walker, 1995).  In these 
experiments, cytochrome b5 reached a maximum when the concentration of ALA was 0.1 mM. 
Any higher concentration of ALA resulted in a decreased concentration of cytochrome b5. 
 In E. coli, ALA is synthesized from the carbon skeleton of glutamic acid.  Rivera used 
labeled glutamate as a source of isotopes to be incorporated into hemes. 13C NMR spectroscopy 
showed that when labeled glutamic acid was used as a heme precursor, the degree of enrichment 
of heme was significantly lower than with labeled ALA. A possible reason for the difference 
might be isotopic dilution caused by the active role of glutamate in other amino acid biosynthetic 
pathways (Rivera & Walker, 1995). 
 
The pyridine hemochrome assay  
 Extinction coefficients of newly-discovered heme proteins are commonly determined via 
the pyridine hemochrome assay (Figure 5).  A hemochrome is a ferroporphyrin complex with 
two axial nitrogenous bases (Berry & Trumpower, 1987).   Pyridine is most commonly used as 
the base.  For heme proteins with b-type hemes [iron protoporphyrin IX], in which the heme is 
not covalently attached to the protein, the protein is denatured to release the heme.  Addition of 
pyridine, followed by the reducing agent sodium dithionite (hydrosulfite) reduces the Fe(III) to 
the Fe(II) form.  Thus, the end product is hemochrome of the free heme (Berry & Trumpower, 
1987).  Berry and Trumpower reported the extinction coefficient for reduced pyridine 
hemochrome b as 34.53 mM-1 cm-1 at 557 nm; data from 525 nm to 620 nm for both the oxidized 
and reduced forms of the complex are reported (Berry & Trumpower, 1987).   Although this 
assay is widely used, it tends to be irreproducible, and advances in this area are desirable. 
 Autoreduction of a heme complex is the uncatalyzed formation of the Fe(II) heme from 
the Fe(III) form by intramolecular electron transfer from one of the axial ligands to the iron.  The 
resulting radical cation of the axial ligand dissociates from the heme, and is replaced by another 
molecule of ligand. Most commonly, autoreduction of Fe(III) to Fe(II) heme occurs by electron-
rich ligands such as aliphatic amines, thiols, pyridines, and cyanide (Hwang & Dixon, 1986).  
The process occurs readily, and addition of aliphatic amines normally gives the Fe(II) 
complexes.  In chloroform or DMSO, the Fe(III) species can be observed, however (Hwang & 
Dixon, 1986).  Hwang and Dixon showed that tertiary amines did not bind at all while secondary 
amines bound only weakly (Hwang & Dixon, 1986).  The rapid autoreduction of aliphatic amine 
complexes encouraged us to try to replace pyridine and dithionite with the primary amine 
butylamine in the pyridine hemochrome assay (Figure 6). 
 
Materials and Methods  
 
Preparation of Luria-Bertani medium broth.  Luria-Bertani (LB) media was prepared with 10 
g tryptone peptone (Becton and Dickinson, Franklin Lakes, NJ), 5 g yeast extract (Becton and 
Dickinson), and 10 g NaCl in 950 ml milliQ water (Barnsteatd International, Dubuque, IA). The 
solution was mixed and the pH was adjusted to 7.0.  Water was added to a total of 1000 ml. The 
broth was autoclaved for 15 min.  Ampicillin (amp) stock solution (100 mg/ml) was prepared by 
diluting 1000 mg ampicillin sodium salt (Fisher, Fairlawn, NJ) in 10 ml of sterile water. After 
the mixture was well dissolved, 1 ml of the stock solution was added to the 1 L LB +amp100 broth 
(final concentration of 100 µg/ml) and the resultant solution was stored at 4 °C.   
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Inoculation and addition of reagents.  From the 1 L of LB + amp100 broth, 5 ml were 
transferred to two 15 ml centrifuge tubes with 5 ml of broth in each. Both tubes were inoculated 
by scraping/stabbing a barely visible amount of Top 10 ShuA-His (gift from Dr. Griselle 
Montañez, Georgia State University) out of the cyrovial with the blunt end of an inoculating 
loop.  The broth was stirred with the same inoculating loop. The cryovial containing Top 10 
ShuA-His was placed back into the freezer at -80 °C immediately. The centrifuge tube caps were 
slightly loosened and a strip of loose tape was placed over the top so that the caps would not fall 
off during shaking in the incubator. Care was taken not to put the tape around the circumference 
of the lid, as this prevents aeration.  Both tubes were grown overnight at 37 °C with shaking at 
200 rpm. 
E. coli growth.  The OD was checked after 16 h with a Shimadzu 1601 UV/vis 
spectrophotometer. Each tube was inverted several times immediately before taking an aliquot 
for the measurement, and the minimum amount possible of the solution was drawn out (~0.5 ml, 
or about to the middle of the cuvette). The OD660 was 1-2. The aliquot was discarded after 
testing. The media (50 ml) was measured into two identical flasks, one being the control and the 
other the experimental.  The centrifuge tubes containing the overnight culture were inverted 
several times to re-suspend the cell material. Each 50 ml flask of LB was inoculated with 0.7 ml. 
Both flasks were again grown at 37 °C with shaking at 200 rpm for 3 h. Arabinose stock solution 
(0.02%) was prepared by diluting 4 g of L-arabinose (Sigma Aldrich, St. Louis, MO) in 200 ml 
of sterile water. The solution was dissolved and filtered through a 0.20 µm Nalgene filter unit 
(MF75 Nalgene Labware, Rochester, NY). Iron sulfate stock solution (0.1 mM) was prepared by 
dissolving 0.1395 g of iron (II) sulfate heptahydrate (MP Biomedicals,) in 5.0 ml of sterile water.  
d-aminolevulinic acid (ALA) stock solution (0.1 mM) was prepared by dissolving 0.0872 g of 
ALA (MP Biomedicals, Irvine, CA) in 5.0 ml of sterile water. After 3 h of shaking arabinose 
stock solution (0.05 ml), iron sulfate stock solution (0.05 ml), and ALA stock solution (0.05 ml) 
were added to the experimental flask, and only 0.05 ml of arabinose was added to the control 
flask. The flasks continued growing at 37 °C with shaking at 200 rpm for 4 h. 
Sonication procedure.  The 50 ml fractions were centrifuged at 8000 x g for 10 min at 4 °C and 
the supernatant was discarded. The pellet from each centrifuge tube was transferred to a 1.7 ml 
centrifuge tube.  Lysis buffer (50 mM Tris, pH 8.0 at 4 °C) was prepared by dissolving 2.42 g of 
20 mM Tris base (MP Biomedicals), 5.84 g of 100 mM NaCl (MP Biomedicals), and 1 ml of 
neat 0.1% Triton (MP Biomedicals) in 1 L of sterile water. Lysis buffer (0.7 ml) was added to 
each tube. The fractions were sonicated (without ice) using a Branson Sonifier 450.  The duty 
cycle was set to 85%.  The output level started at 2 for a one min sonication (without ice).  The 
fraction was allowed to stand for two min at room temperature.  Subsequent sonications were 
performed at output levels of 3 and 4, again without ice, and again with a two minute interval at 
room temperature between sonications.  The tubes were centrifuged and spectra were taken. 
Nickel affinity fast protein liquid chromatography (FPLC).  A new nickel column (HiTrap 
chelating 5 ml, Amersham Biosciences, Piscataway, NJ) was washed with 20 column volumes 
(CV) of water prior to charging to remove any contaminants present.  The column was stripped 
with 5 CV nickel chelating column buffer (binding buffer) (Figure 7).  Binding buffer was 
prepared as follows.  A 500 ml solution of 1.00 M K2HPO4 (Fisher Scientific, Fair Lawn, NJ) 
was prepared by the addition of K2HPO4 (87.09 g) to a 500 ml volumetric flask and dilution to 
the mark.  A 500 ml solution of 1.00 M KH2PO4 (Fisher) was prepared by addition of KH2PO4 
(68.05 g) to a 500 ml volumetric flask and dilution to the mark. Portions of the K2HPO4 solution 
(80.2 ml), KH2PO4 (19.8 ml), and solid NaCl (29.22 g) were added to a 2 L Pyrex bottle and 
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were diluted to the mark. The pH was adjusted to 7.4.  The final solution was 50 mM in with 
potassium phosphate (50 mM) and 250 mM in NaCl.  The solution was filtered using a MF75 
Nalgene vacuum filter unit.   
 The column was charged with a 0.1 M nickel chloride solution, which was prepared by 
the addition of nickel chloride (4.4 g) (Mallinckrodt Chemical Works, St. Louis, MO) to a 100 
ml volumetric flask and dilution with milliQ water to 100 ml. The solution was vacuum filtered 
before use.  
 The pump and column were washed with ten CV of water to remove any ethanol 
preservative or stripping buffer remaining in the FPLC from previous runs. The column was 
equilibrated with five CV of binding buffer and a flow rate of 1.0 for 30 min. The super loop (50 
ml) was washed with milliQ water.  The concentrated SiaA sample was then injected into the 
superloop. One line was placed into the binding buffer, and another line was placed into the 
elution buffer (lysis buffer).  After SiaA was purified and collected, the pumps were washed 
again with water and 20% ethanol.   
Growth at low temperature.  To see if a lower incubation temperature and a slower shaking 
speed would increase the yield of protein, the procedure above was followed, but the shaking 
speed, temperature and duration were changed.  After the inoculation was completed, the beakers 
containing the 50 ml samples were grown at 24 °C with shaking at 100 rpm for 3 h.  After 
addition of the stock solution, arabinose, ALA and iron sulfate the beakers were incubated at 24 
°C with shaking at 100 rpm. The OD of the solution was taken after 1, 2 and 4 days.  The protein 
was isolated on day 5.   
Autoreduction of myoglobin by butylamine.  A solution of NaOH (1.0 ml of 1.0 M, Fisher 
Scientific, Fair Lawn, NJ) was added to a 15 ml centrifuge tube.  A small amount of myoglobin 
(equine skeletal muscle, Sigma-Aldrich, St. Louis, MO) was added to give a Soret band between 
0.2 and 2.0.  Butylamine (4 ml, Aldrich, Milwaukee, WI) was added and the tube was filled to 
the 10 ml mark with milliQ water (5 ml) to give a solution of 40% final concentration of 
butylamine. The solution was vortexed and an immediate spectrum was taken; the solution was 
not fully reduced. An 80% butylamine solution was then prepared by the addition of NaOH (1.0 
ml of 1.0 M) to a 15 ml centrifuge tube.  A small amount of myoglobin was added to give a Soret 
band between 0.2 and 2.0.  Butylamine (8 ml), was added and the tube was filled to the 10 ml 
mark with milliQ water (1 ml). The solution was vortexed and an immediate spectrum was 
obtained. 
 A solution of sodium dithionite in water was prepared.  MilliQ water (3 ml) was degassed 
with nitrogen (pre-purified, Airgas) for approximately 10 min.  Sodium dithionite (0.0564 g, 
Fisher Scientific, Fair Lawn, NJ) was added to the water. The myoglobin solution in aqueous 
butylamine solution was degassed for approximately 10 min as well.  An aliquot of saturated 
sodium dithionite solution (1.6 µL) was added to the myoglobin solution and the spectrum was 
recorded.  A second aliquot of 22.0 µL of the dithionite solution was added to the same 
myoglobin solution and the spectrum retaken.    
 
Results 
 
Addition of ALA to the growth medium   
 Because ALA is expensive, our first goal was to determine the minimum volume of 
growth solution that would give reproducible results. Starting with 500 ml samples and working 
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with increasingly smaller volumes, a 50 ml sample was found to be the smallest volume that 
could be used to provide reproducible results. 
 Our second goal was to establish whether the addition of ALA enhanced the production 
of the holoprotein.  A preliminary experiment involved a direct comparison of the bacteria grown 
with and without ALA on the 50 ml scale. ALA and FeSO4 stock solutions (0.1 M each) were 
added to only one beaker to give solutions that were 0.1 mM in both reagents.  The reactions 
were taken through the sonication and centrifugation steps.  The supernatant of each sample was 
analyzed via UV/vis (Figures 8 and 9). The amount of heme protein was evaluated using an 
extinction coefficient 1.03 x 105 M-1 cm-1 at 424 nm (B. Sook, unpublished).  The total amount of 
holoprotein found in the control was approximately 0.46 mg in 50 ml, which extrapolates to a 
total of 9.13 mg/L.  When the bacteria was grown with ALA and FeSO4, a very broad Soret was 
observed (Figure 9), consistent with both holoprotein and free heme in solution. Assuming that 
the absorbance at 424 represents only the holoprotein, this experiment indicates that 0.49 mg of 
holoprotein was formed in 50 ml, extrapolating to a total of about 9.71 mg/L of culture.  To the 
extent that the absorbance at 424 nm is a shoulder of free heme, the final concentration of SiaA 
will be lower than that calculated.  Thus, it appears that ALA substantially increases the amount 
of heme available in the cell, but does not significantly increase the amount of holoprotein.   
 These same two reactions were each concentrated and run through nickel affinity FPLC, 
using imidazole to elute the His-tagged protein from the column (Figure 10).  SiaA produced 
without ALA and FeSO4 eluted at 59.2 min (Figure 11).  Spectra of fractions 14-19 (2 ml each) 
are shown in Figure 12.  The positions of the Soret and α,β bands indicate that the protein is in 
the ferric form, as expected.  Using an extinction coefficient of 9.6 x 104 M-1 cm-1 at 415 nm (S. 
Sumithran, unpublished), the total protein concentration in tubes 14 to 19 was determined to be 
approximately 5.0 mg.  Thus, about 50% of the protein was isolated after the nickel affinity 
column step. 
SiaA produced with ALA and FeSO4 eluted at 84.5 min (later than in the previous run 
because the imidazole gradient was started much later) (Figure 13).  Spectra of fractions 24-30 
(0.5 ml each) are shown in Figure 14.  The total protein concentration in tubes 24 to 30 was 
determined to be approximately 0.2 mg.  Thus, it appears that much less of the protein was 
recovered in the ALA and FeSO4 run.  However, if the free heme had contributed significantly to 
the apparent Soret of the protein sample before FPLC, the amount of holoprotein before the 
FPLC step could have been overestimated, as described above.    
 
The oxidation state of the heme in SiaA   
 In this work, SiaA was isolated as reduced [i.e., in the Fe(II) state] for the first time 
(Figure 1).  Previous work in the laboratory had always led to the ferric [Fe(III)] protein.  Figure 
15 shows SiaA to be reduced because the positions of the Soret at 421 nm, the α peak at 558 nm 
and the ß peak at 541 nm match those previously recorded for the reduced form of pure protein 
(B. Sook, unpublished). The ratio of the α to ß was 1.39, which is also the same as that for 
previously recorded data (1.40) (B. Sook, unpublished). Therefore, the protein was reduced as 
isolated. Figure 15 also demonstrates that SiaA becomes oxidized in 48 h under regular 
conditions.  The observation of reduced protein in these preparations may be due to rapid workup 
of the cells. 
 The extinction coefficient of the protein has been measured using the pyridine 
hemochrome technique as 9.6 x 104 M-1 cm-1 at 415 nm.  Reduction of a solution gave a spectrum 
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that allowed calculation of the extinction coefficient of the ferrous form of the protein as 1.03 x 
105 M-1 cm-1 at 424 nm (B. Sook, unpublished). 
 
 
 
Growth at low temperature   
 Bacterial growth both in the absence and the presence of ALA and ferrous sulfate was 
studied under two different conditions:  37 oC at 200 rpm for 7 h (described above) and 24 oC at 
100 rpm for 3 d. The initial inoculation solution was grown for 19.75 h, at which time the OD660 
was 1.9 (Figure 16).  An aliquot of this solution was added to each of two 50 ml flasks of growth 
medium.  Figure 17 displays the spectrum after 3 h of growth and before the addition of stock 
solutions. Arabinose was added to one solution and arabinose, ALA and ferrous sulfate were 
added to the other solution.  Each sample was grown at 24 oC at 100 rpm.  The spectra of these 
solutions after 48 h are shown in Figures 18 and 19, respectively.  After 3 d of shaking, the 
sample containing ALA had a slightly greater Soret than that without the addition of ALA 
(Figure 20).  
 The UV/vis confirms the small amount of heme at 24 oC, even with ALA and ferrous 
sulfate, as seen from the reduced absorbance at the Soret (Figure 21 and 22).  The samples grown 
at 24 oC both gave oxidized protein, whereas the samples grown at 37 oC gave reduced or largely 
reduced protein (Figure 23).  The samples grown at 24 oC were much paler in color than the 
corresponding solutions grown at 37 oC, even though the former were grown for 3 d and the 
latter for 7 h.   
 
Modification of the pyridine-hemochrome assay   
Butylamine was used instead of pyridine and dithionite to create a reduced hemochrome 
solution [Fe(II) heme with two axial ligands] (Figure 6).  In the first experiment, the myoglobin 
was treated first with 1.0 M NaOH, and then with butylamine and water to give a final solution 
that was 0.1 M NaOH and 40% butylamine.  This solution was stable for three h (Figure 24).  
However, the heme did not fully reduce, as shown by spectral changes on the addition of a small 
amount of solid sodium dithionite (data not shown).   
 The reaction was rerun, but with final concentrations of 0.1 M NaOH and 80% 
butylamine.  Immediately after preparation, the spectrum of this solution was already 
significantly reduced (Figure 25).  The solution autoreduced fairly rapidly, turning from a yellow 
color to a light pink.  The solution remained stable over a period of 3 h.   Addition of aqueous 
sodium dithionite did not result in additional reduction (Figure 26).  A subsequent experiment 
indicated that autoreduction was largely complete in only a few minutes after the addition of the 
butylamine in solutions with 80% butylamine. 
 
Discussion 
 
Addition of ALA to the growth medium   
In previous work, SiaA was not fully heme loaded as isolated.  In our laboratory it was 
about 60% holo and 40% apo (B. Sook, unpublished); Lei et al. isolated a protein that was about 
85% holo and 15% apo (Lei et al., 2003). The observation in both laboratories that the protein 
was not produced in the fully holo form may indicate that there was not enough heme in the cell 
or that some forms of proteins were not able bind heme, even when it was available.  Because it 
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has been difficult to reconstitute the protein in our laboratory, we desired to change the growth 
medium to produce more heme in the cell, on the hypothesis that perhaps the protein was not 
fully heme loaded because there was not enough heme in the cell.  To increase the amount of 
heme in the cell, we followed the work of Rivera and Walker by adding ALA to the growth 
medium to enhance heme biosynthesis (Rivera & Walker, 1995). Our work showed that 
experiments could be run reliably on the 50 ml scale.    
 In this work, we observed that growth with 0.1 M ALA produced free heme, (i.e., not 
bound in the protein). The increased amount of free heme due to growth with ALA is consistent 
with previous work by Rivera and Walker (Rivera & Walker, 1995).  The Soret of the 
holoprotein was very similar intensity with and without ALA and ferrous sulfate.  Thus, it 
appears that addition of ALA and ferrous sulfate does not increase the amount of holoprotein. 
  A more detailed assessment of the effect ALA and ferrous sulfate was made by doing the 
first chromatography step involved in isolating pure protein (Figure 27).  Fractions from a nickel 
affinity column were collected, and the absorbance of each measured at the Soret.  Summation of 
all of the holoprotein derived from a 50 mL growth showed that 5.03 mg of holoprotein were 
obtained without the addition of ALA and 0.19 mg of holoprotein were obtained with the 
addition of ALA.  As for the spectral measurements before the nickel affinity column, this 
analysis shows that the addition of ALA and ferrous sulfate do not increase the amount of 
holoprotein. With this analysis, however, it appears that ALA and ferrous sulfate actually 
decrease the amount of holoprotein.  The discrepancy is not yet resolved.  Further work might 
involve growing the bacteria with lower concentrations of ALA and ferrous sulfate.  Hemin is 
known to dimerize, and it might be that a lower concentration of hemin in solution would 
provide more monomer for uptake by the apoprotein. 
 
The oxidation state of the heme in SiaA   
The UV/vis spectra of SiaA show that it is isolated as the reduced protein.  The isolation 
of the reduced protein, even after a workup taking many hours, indicates that SiaA is very stable 
in its reduced form.  Rodgers and Evans have found that SiaA has a redox potential of about 75 
mV (though the process is not fully reversible) (K. Rodgers and D. Evans, personal 
communication).  Isolation of a mixture of the oxidized and reduced form of the heme has also 
been reported for IsdE, a SiaA homolog from Staphylococcus aureus (Mack et al., 2004).   
 Reduction potentials are known for two other b-type hemes with Met and His axial 
ligands.  Cellobiose dehydrogenase has reported redox potentials of 164 mV and 130 mV 
(Igarashi et al., 1999).  Cytochrome b562 also has Met and His axial ligands and a reported 
reduction potential of 160 mV (Barker et al., 1996).  The protein itself is very important in 
controlling the redox potential.  For example, c-type hemes with Met and His axial ligands have 
reported reduction potentials ranging from 450 to -60 mV (Gibney Database, 
http://heme.chem.columbia.edu/hemedetail.php). 
 The internal redox set point of E. coli is estimated to be approximately -0.3 V (de Graef 
et al., 1999).  Thus, it is expected that SiaA, with a reduction potential of 75 mV, will be found 
largely in the oxidized state in the cell.  The observation that it is isolated in the reduced form 
presumably indicates that some protein(s) in E. coli reduces SiaA during cell growth. 
 
Growth at low temperature   
When growing recombinant heme proteins in E. coli, it is not uncommon to find that the 
recombinant protein is not fully in the holoprotein form.  As pointed out above, we usually 
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isolate SiaA with only about 60% heme loading.  The heme uptake protein ShuT is isolated with 
only about 10-20% heme loading (Eakanunkul et al., 2005).  One possibility for low heme 
loading is that heme biosynthesis in E. coli cannot make enough heme to fully load the 
recombinant apoprotein.  One solution is to grow the bacteria at lower temperatures.   While 
lower temperatures are expected to slow both the growth of the mutant protein and the 
production of heme, it has been found empirically that growing the bacteria at lower 
temperatures gives higher fractions of holoprotein in some instances (A. Thompson and T. 
Holman, personal communication).   
 For SiaA, growing the bacteria at 24 oC for 3 d gave a much lower final concentration of 
heme than growing at 37 oC for 7 h.   Thus, this technique of growing at lower temperatures does 
not seem to increase the holoprotein for SiaA.  Growing at the lower temperature gave oxidized 
protein, whereas growing at the higher temperature usually gives partially or fully reduced 
protein.  This is presumably because the bacteria grown at 24 oC were shaken in an oxygen 
atmosphere for approximately nine times longer than those grown at 37 °C, resulting in oxidation 
of the SiaA. 
 
 
Modifications of the pyridine-hemochrome assay  
 A variety of amines are known to autoreduce hemes (Hwang & Dixon, 1986).   
Autoreduction is thought to be a light-induced process, but in many cases room light is enough to 
effect full reduction (D. Dixon, personal communication).  Autoreduction is thought to occur by 
initial transfer of an electron from the amine to the Fe(III) center, followed by dissociation of the 
amine cation, and binding of another amine to the Fe(II) center. Butylamine autoreduces hemin 
quickly under some circumstances (Hwang & Dixon, 1986).   
 In the current series of experiments, we observed facile reduction of the hemin from 
myoglobin with 80% butylamine, but not with 40% butylamine (Figure 24 and 25).   The 
reduced hemochrome in the 80% butylamine solution was also stable for at least 3 h.   
 An advantage to using butylamine instead of pyridine and sodium dithionite is that the 
tailing due to sodium dithionite is eliminated.  In the pyridine hemochrome assay, a small 
amount of sodium dithionite did not fully reduce the myoglobin (1.6 µL of saturated aqueous 
solution).  A larger amount (23.6 µL total of saturated aqueous solution) gave dithionite 
absorbance under the heme peak, which reduced the accuracy of measuring the absorbance ratios 
in order to determine the extinction coefficient.  Since the 80% butylamine solution gave 
complete autoreduction without the need for sodium dithionite, bubbling with gas was not 
necessary.  Thus, the butylamine solution protocol was less labor intensive.  The new technique 
was also more reproducible and more accurate than the pyridine hemochrome assay. With further 
experimentation we hope to replace the pyridine hemochrome assay, which is generally viewed 
as difficult and prone to error. 
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Protoporphyrin IX   Heme (Reduced)  Hemin (Oxidized) 
 
Figure 1: The structures of protoporphyrin and heme (reduced) and hemin (oxidized). 
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Figure 2. Structure of the ten gene operon expressed by S. pyogenes. 
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Gram Positive Heme ATP Binding Cassette 
Transport System (ABC)
N
NN
N
COO--OOC
Fe2+
• The heme (red) is bound to the protein SiaA (bright blue)
• The lipoprotein tail anchors the protein to the membrane.
• The heme goes through the membrane permease, which is composed of 
SiaB and SiaC. It then enters the cytoplasm.
 
 
 
 
Figure 3. Heme binding protein, SiaA and its ABC transporter. 
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Linear tetrapyrrole
 
 
 
Figure 4. The structure of δ-aminolevulinic acid (ALA), the first committed precursor in the 
biosynthetic pathway of heme (Top). A schematic of the heme biosynthetic pathway (Bottom).   
HO NH2
O
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Pyridine Hemochrome
• Extinction coefficients of newly-discovered heme proteins are commonly 
determined via the pyridine hemochrome assay. 
• Pyridine is most commonly used as the base.  For heme proteins with b-
type hemes [iron protoporphyrin IX], in which the heme is not covalently 
attached to the protein, the protein is denatured to release the heme.  
Addition of pyridine, followed by the reducing agent sodium dithionite 
(hydrosulfite) reduces the Fe(III) to the Fe(II) form. 
• Although this assay is widely used, it tends to be irreproducible, and 
advances in this area are desirable.
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Figure 5.  Graphical description of the pyridine hemochrome assay. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Butylamine as an Autoreducer
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• Autoreduction of Fe(III) to Fe(II) heme 
occurs by electron-rich ligands such as 
aliphatic amines.
• Butylamine solution (40%) was found 
to partially autoreduce hemin.
• Butylamine solution (80%) was found 
to fully autoreduce hemin.
• Both solutions of butylamine remain 
stable over 3 hours. 
• Autoreduction does not require 
sodium dithionite, and is less labor 
intensive than the pyridine 
hemochrome assay.
Butylamine
hv
Fe II
Butylamine
Butylamine
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Figure 6. Graphical description of the butylamine hemochrome assay. 
 
Protocol step Comments Numerical 
setting 
Notes 
Flow rate  0.2 ml/min   
Start pump wash Wash inlet A On  
 Wash inlet B On  
Start conc B % B 0  
Column equilibrate  Equilibrate w/  0 CV Normally 5-10 CV. 
Equilibrate the column with buffer A. 
Flowthrough fractionation  8 ml Can be adjusted 
Sample injection Empty loop w/  X ml   
Wash out unbound sample Wash column w/  10 CV 5-10 CV 
Volume fractionation Start fraction at % B 0 %  
Start elution End fraction (% B) 100 %  
Volume fractionation Eluate fraction size 2 ml Can be adjusted 
Linear gradient Target conc B (% B) 100 %  
 Length of gradient 10 CV  
Gradient delay Gradient delay 5 ml  
Clean after elution Clean w/ CV 5 CV  
 
 
 
Figure 7.  FPLC settings for purification of the SiaA protein.   
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Figure 8.  Control (50 ml) grown at 37° C and 200 rpm for 7 h followed by centrifugation, 
sonication and centrifugation again. The absorbance is approximately 1.5 at the Soret.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.  Addition of ALA and ferrous sulfate (50 ml) and grown at 37° C and 200 rpm for 7 h 
followed by centrifugation, sonication and centrifugation again. The absorbance is approximately 
2.3 at the Soret.  
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Expression and Purification at 37 °C
E. coli was grown 
with plasmid of 
SiaA overnight
E. coli was added to 
LB broth; 37 °C with 
shaking at 200 rpm
Arabinose was added to 
control. ALA and FeSo4
was added to the 
experimental.
Centrifuged and supernatent was 
discarded.
Solution was centrifuged 
again on smaller scale.
Cells lysed in extraction buffer 
with sonication
Ni Affinity FPLC
4 hours
3 hours
UV/vis was used to calculate 
amount of holoprotein in SiaA.
 
Figure 10.  Expression, growth and purification protocol of SiaA with and without ALA at 37 oC 
with shaking at 200 rpm for 7 h. 
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Figure 11. Nickel affinity FPLC chromatogram performed on Figure 8, sonicated, centrifuged, 
and filtered supernatant (no addition of ALA and FeSO4 to the growth medium).  Dotted line 
starting at fraction 6 indicates a linearly increasing concentration of elution buffer (binding 
buffer with 0.5 M imidazole). SiaA eluted at 59.2 min.  
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Figure 12. Spectra of individual FPLC fractions for the Ni affinity purification of the protein 
from cells grown without the addition of ALA and ferrous sulfate. The Figure continues on the 
next 2 pages. 
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Figure 13. Nickel affinity FPLC chromatogram performed on Figure 9, sonicated, centrifuged, 
and filtered supernatant (with addition of ALA and FeSO4 to the growth medium).  Dotted line 
starting at fraction 16 indicates a linearly increasing concentration of elution buffer (binding 
buffer with 0.5 M imidazole). SiaA eluted at 84.45 min.  
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Figure 14.  Spectra of individual FPLC fractions for the Ni affinity purification of the protein 
from cells grown with the addition of ALA and ferrous sulfate. The Figure continues on the next 
3 pages. 
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Figure 15.  Control (50 ml) grown at 37 °C and 200 rpm for 7 h followed by centrifugation, 
sonication and centrifugation again. The protein was initially isolated as reduced after the second 
centrifugation. After 48 h of being exposed to oxygen, the protein becomes oxidized.  
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Figure 16.  E. coli were grown at 37 °C with shaking at 200 rpm for 19.75 h. This spectra was 
obtained before the addition of arabinose, ALA or Fe(II)SO4.  The OD660 is approximately 1.9.  
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Figure 17.  E. coli were grown at 24 °C with shaking at 100 rpm for 3 h. This spectra was 
obtained before the addition of arabinose, ALA or Fe(II)SO4.  The OD660 is less than 0.1.  
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Figure 18.  Arabinose was added to the sample in Figure 17 which was then grown at 24 °C with 
shaking at 100 rpm for 48 h.  
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Figure 19.  Arabinose, ALA or Fe(II)SO4 were added to the sample identical to that in Figure 17.  
The sample was then grown at 24 °C with shaking at 100 rpm for 48 h.  
 31
Control LT OD before centrifuge 10-13-06 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
250 300 350 400 450 500 550 600 650 700
Wavelength (nm)
A
bs
or
ba
nc
e
 
 
 
ALA LT OD before cenrifuge 10-13-06 Libkind 54
0
0.5
1
1.5
2
2.5
3
250 300 350 400 450 500 550 600 650 700
Wavelength
A
bs
or
ba
nc
e
 
 
Figure 20.  The samples from Figure 18 (top) and 19 (bottom) after 3 d of growth (just before 
centrifugation). 
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Figure 21.  E. coli grown without ALA and ferrous sulfate at 24 °C with shaking at 100 rpm for 
3 days.   
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Figure 22.  E. coli grown in the presence of ALA and FeSO4 24 °C with shaking at 100 rpm for 3 
days.   
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Production of Heme at Different Temperatures
50 ml ALA sample at low temperature 10-13-06
0
0.5
1
1.5
2
2.5
3
3.5
4
250 300 350 400 450 500 550 600 650 700
Wavelength (nm)
A
bs
or
ba
nc
e
50 ml sample with 0.1 mM ALA 4-11-06
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• SiaA grown at 37 °C (top 
spectrum) displays a larger 
Soret in comparison to SiaA 
grown at 24 °C (bottom 
spectrum).
• The larger Soret represents 
more free heme when grown at 
37 °C, but not more holoprotein.
• Growth at 24 °C produces 
approximately four times less 
free heme than at 37 °C. 
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Figure 23.  Comparison of growth of E. coli with SiaA at 37 oC and 24 oC. 
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Figure 24.  Myoglobin treated first with 0.1 M NaOH with subsequent addition of 40% 
butylamine solution (top).  The heme is not fully reduced.  After 3 h, the heme is still not fully 
reduced (bottom). All solutions were in air. 
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Figure 25.  Myoglobin treated first with 0.1 M NaOH and then with butylamine to give a final 
solution of 80% butylamine (all solutions in air).  Top:  Spectra take directly after the addition of 
butylamine.  Bottom:  Spectrum taken after 2 h in room light.  The sample appears completely 
reduced after mixing, and does not change over 3 h. 
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Figure 26.  The solution in Figure 25 (bottom) (3 mL) was bubbled with nitrogen for 10 min.  
Top:  To this sample was added 1.6 µL of saturated aqueous solution of sodium dithionite.  No 
addition reduction is seen.  Bottom:  Another 22 µL of saturated aqueous sodium dithionite 
solution were added.  Significant absorption under the Soret due to the dithionite is observed. 
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Figure 27.  General protocol for expression and purification of SiaA.  
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